Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Hillen, U; Ulrich, M; Alter, M; Becker, JC; Gutzmer, R; Leiter, U; Lonsdorf, A; Messerschmidt, A; Ulrich, C.
[Cutaneous squamous cell carcinoma: a review with consideration of special patient groups].
Hautarzt. 2014; 65(7):590-599
Doi: 10.1007/s00105-013-2734-7
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Becker Jürgen Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The incidence of non-melanoma skin cancer (NMSC) is increasing. Squamous cell carcinoma of the skin (SCC) is a tumor of the elderly. Due to the increasing life expectancy, SCC will become more and more frequent in the future. Generally SCC has a favorable prognosis. Standard therapy is microscopically- controlled excision. Therapy of advanced and metastatic SCC is still challenging. Patients with regional lymph node metastasis have ten-year survival rates less than 20%; patients with distant metastases less than 10%. Immunosuppression has been shown to be one of the key prognostic factors for metastasis. The article reviews SCC and focusses on patients being at risk for an unfavorable course.
- Find related publications in this database (using NLM MeSH Indexing)
- Age Distribution -
- Antineoplastic Agents - therapeutic use
- Carcinoma, Squamous Cell - mortality
- Carcinoma, Squamous Cell - pathology
- Carcinoma, Squamous Cell - therapy
- Dermatologic Surgical Procedures - methods
- Humans -
- Incidence -
- Risk Assessment -
- Risk Factors -
- Sex Distribution -
- Skin Neoplasms - mortality
- Skin Neoplasms - pathology
- Skin Neoplasms - therapy
- Survival Rate -
- Find related publications in this database (Keywords)
- Non-melanoma skin cancer
- Therapy
- Lymph node metastasis
- Distant metastases
- Immunosuppression